期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Methylene Blue:An FDA-Approved NIR-II Fluorogenic Probe with Extremely Low pH Responsibility for Hyperchlorhydria Imaging
1
作者 Guanjun Deng Siwei Zhang +7 位作者 Xinghua Peng Gongcheng Ma Luxuan Liu Yuyu Tan Ping Gong Ben Zhong Tang Lintao Cai Pengfei Zhang 《Chemical & Biomedical Imaging》 2024年第10期683-688,共6页
Methylene blue(MB)is an FDA(Food and Drug Administration)-approved contrast agent with donor−acceptor(D−A)structure integrated with carbonyl-containing nitrogen-heterocycles.MB can be converted into MBH(protonated MB)... Methylene blue(MB)is an FDA(Food and Drug Administration)-approved contrast agent with donor−acceptor(D−A)structure integrated with carbonyl-containing nitrogen-heterocycles.MB can be converted into MBH(protonated MB)by protonation,which not only induces the fluorescence emission redshifted from the first near-infrared window(NIR-I,650−950 nm)to the second near-infrared window(NIR-II,1000−1700 nm)but also achieves ACQ-to-AIE conversion.MB has been successfully demonstrated in hyperacidemia imaging with an extremely low pH value(<1). 展开更多
关键词 aggregation-induced emission NIR-II fluorescence gastric hyperacidity pH detection FDA-approved
在线阅读 下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部